Current trends in biotechnology of drugs applied in cardiovascular diseases - recombinant proteins, peptide analogues and antisense oligonucleotides

• Authors: Cz. Cierniewski , M. Stasiak
• Languages of publication: PL

Abstracts

EN

This lecture consist of three parts, the first one gives a summary of mechanisms regulatting hemostasis and fibrynolysis, the second - discusses potential target molecules for therapeutic intervention, and the third one describes recent studies on selective inhibition of certain pathophysiological processes by molecules designed to prevent cardiovascular problems.Thus, a critical review of current trends in biotechnology of drugs which recently have been designed and tested to improve survival of patients with different cardiovascular diseases is provided.

Keywords

EN

CARDIOVASCULAR DISEASE; FIBRYNOLYSIS; HEMOSTASIS

Discipline

• BIOTECHNOLOGY: BIOTECHNOLOGY

• Publisher: Committee of Biotechnology, Polish Academy of Sciences
• Journal: Biotechnologia
• Year: 1996
• Issue: 3
• Pages: 11-22

Contributors

author

Cz. Cierniewski

author

M. Stasiak

• Document Type: article
• Publication order reference: Cz.Cierniewski